GLP1 Supplements

GLP-1 Cholesterol Improvements: What The Data A...

GLP-1 cholesterol improvements data: trials show triglycerides drop ~19–24% while LDL falls modestly. Learn which labs to track and how to interpret changes.

GLP-1 Cholesterol Improvements: What The Data A...

GLP-1 cholesterol improvements data: trials show triglycerides drop ~19–24% while LDL falls modestly. Learn which labs to track and how to interpret changes.

GLP-1 Blood Pressure Changes: What To Expect An...

GLP-1 blood pressure changes explained: why semaglutide/tirzepatide may lower or spike BP, typical 2–5 mm Hg drops, red flags, and safe home monitoring.

GLP-1 Blood Pressure Changes: What To Expect An...

GLP-1 blood pressure changes explained: why semaglutide/tirzepatide may lower or spike BP, typical 2–5 mm Hg drops, red flags, and safe home monitoring.

GLP-1 Atherosclerosis Plaque Research: What The...

GLP-1 atherosclerosis plaque research, explained: what trials and imaging suggest about plaque stability vs shrinkage, plus ApoB/Lp(a) labs and CAC/CTA options.

GLP-1 Atherosclerosis Plaque Research: What The...

GLP-1 atherosclerosis plaque research, explained: what trials and imaging suggest about plaque stability vs shrinkage, plus ApoB/Lp(a) labs and CAC/CTA options.

Retatrutide Cardiovascular Trial Results: What ...

Retatrutide cardiovascular trial results: no public MACE data yet. See what early trials show for BP, lipids and hsCRP, plus the TRIUMPH-OUTCOMES timeline.

Retatrutide Cardiovascular Trial Results: What ...

Retatrutide cardiovascular trial results: no public MACE data yet. See what early trials show for BP, lipids and hsCRP, plus the TRIUMPH-OUTCOMES timeline.

GLP-1 Stroke Prevention Evidence: What We Know ...

GLP-1 stroke prevention evidence in 2026: what trials show for semaglutide/tirzepatide, who benefits most, and how to discuss stroke risk with your clinician.

GLP-1 Stroke Prevention Evidence: What We Know ...

GLP-1 stroke prevention evidence in 2026: what trials show for semaglutide/tirzepatide, who benefits most, and how to discuss stroke risk with your clinician.

Mounjaro And Cardiovascular Risk Reduction: Wha...

Mounjaro cardiovascular risk reduction: what trials show on heart attack/stroke risk, plus how tirzepatide affects BP, A1C, visceral fat, and kidneys.

Mounjaro And Cardiovascular Risk Reduction: Wha...

Mounjaro cardiovascular risk reduction: what trials show on heart attack/stroke risk, plus how tirzepatide affects BP, A1C, visceral fat, and kidneys.